451 related articles for article (PubMed ID: 25437978)
1. Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
Buzney E; Sheu J; Buzney C; Reynolds RV
J Am Acad Dermatol; 2014 Nov; 71(5):859.e1-859.e15; quiz 873-4. PubMed ID: 25437978
[TBL] [Abstract][Full Text] [Related]
2. Androgens in women: Hormone-modulating therapies for skin disease.
Azarchi S; Bienenfeld A; Lo Sicco K; Marchbein S; Shapiro J; Nagler AR
J Am Acad Dermatol; 2019 Jun; 80(6):1509-1521. PubMed ID: 30312645
[TBL] [Abstract][Full Text] [Related]
3. The treatment of polycystic ovary syndrome.
Ajossa S; Guerriero S; Paoletti AM; Orrù M; Melis GB
Minerva Ginecol; 2004 Feb; 56(1):15-26. PubMed ID: 14973407
[TBL] [Abstract][Full Text] [Related]
4. Hirsutism and acne in polycystic ovary syndrome.
Archer JS; Chang RJ
Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):737-54. PubMed ID: 15380144
[TBL] [Abstract][Full Text] [Related]
5. Interventions for hirsutism (excluding laser and photoepilation therapy alone).
van Zuuren EJ; Fedorowicz Z; Carter B; Pandis N
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010334. PubMed ID: 25918921
[TBL] [Abstract][Full Text] [Related]
6. Antiandrogen treatment of polycystic ovary syndrome.
Rittmaster RS
Endocrinol Metab Clin North Am; 1999 Jun; 28(2):409-21. PubMed ID: 10352926
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness and safety of treatments used for polycystic ovarian syndrome management in adolescents: a systematic review and network meta-analysis protocol.
Al Khalifah RA; Flórez ID; Dennis B; Neupane B; Thabane L; Bassilious E
Syst Rev; 2015 Sep; 4():125. PubMed ID: 26420636
[TBL] [Abstract][Full Text] [Related]
8. Androgen excess: Investigations and management.
Lizneva D; Gavrilova-Jordan L; Walker W; Azziz R
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():98-118. PubMed ID: 27387253
[TBL] [Abstract][Full Text] [Related]
9. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of commonly used medical treatments for hirsutism in women.
Koulouri O; Conway GS
Clin Endocrinol (Oxf); 2008 May; 68(5):800-5. PubMed ID: 17980017
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome.
Al-Inany H
Clin Evid; 2004 Dec; (12):2678-88. PubMed ID: 15865813
[No Abstract] [Full Text] [Related]
12. Comparison of four different treatment regimes in hirsutism related to polycystic ovary syndrome.
Gökmen O; Senöz S; Gülekli B; Işik AZ
Gynecol Endocrinol; 1996 Aug; 10(4):249-55. PubMed ID: 8908525
[TBL] [Abstract][Full Text] [Related]
13. Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.
van Zuuren EJ; Fedorowicz Z
Br J Dermatol; 2016 Jul; 175(1):45-61. PubMed ID: 26892495
[TBL] [Abstract][Full Text] [Related]
14. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome.
Harborne L; Fleming R; Lyall H; Sattar N; Norman J
J Clin Endocrinol Metab; 2003 Sep; 88(9):4116-23. PubMed ID: 12970273
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines.
Bird ST; Hartzema AG; Etminan M; Brophy JM; Delaney JA
Gynecol Endocrinol; 2013 Apr; 29(4):365-9. PubMed ID: 23311996
[TBL] [Abstract][Full Text] [Related]
16. Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a one-year randomized clinical trial.
Alpañés M; Álvarez-Blasco F; Fernández-Durán E; Luque-Ramírez M; Escobar-Morreale HF
Eur J Endocrinol; 2017 Nov; 177(5):399-408. PubMed ID: 28912358
[TBL] [Abstract][Full Text] [Related]
17. Clinical Inquiry: What therapies alleviate symptoms of polycystic ovary syndrome?
Moreno LE; Bonnell A; Neher JO; Safranek S
J Fam Pract; 2015 Apr; 64(4):247-9. PubMed ID: 25973451
[TBL] [Abstract][Full Text] [Related]
18. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
Costello M; Shrestha B; Eden J; Sjoblom P; Johnson N
Cochrane Database Syst Rev; 2007 Jan; (1):CD005552. PubMed ID: 17253562
[TBL] [Abstract][Full Text] [Related]
19. Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.
Franks S; Layton A; Glasier A
Hum Reprod; 2008 Feb; 23(2):231-2. PubMed ID: 18083746
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.
Bhattacharya SM; Jha A
Fertil Steril; 2012 Oct; 98(4):1053-9. PubMed ID: 22795636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
